BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25592709)

  • 1. Novel synthetic coumarins that targets NF-κB in Hepatocellular carcinoma.
    Neelgundmath M; Dinesh KR; Mohan CD; Li F; Dai X; Siveen KS; Paricharak S; Mason DJ; Fuchs JE; Sethi G; Bender A; Rangappa KS; Kotresh O; Basappa
    Bioorg Med Chem Lett; 2015 Feb; 25(4):893-7. PubMed ID: 25592709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.
    Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J
    Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
    Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
    Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
    Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
    Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
    Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
    Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
    Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
    Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF-κB increased expression of 17β-hydroxysteroid dehydrogenase 4 promotes HepG2 proliferation via inactivating estradiol.
    Lu X; Ma P; Shi Y; Yao M; Hou L; Zhang P; Jiang L
    Mol Cell Endocrinol; 2015 Feb; 401():1-11. PubMed ID: 25448063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of NF-kappaB in hepatocellular carcinoma cell.
    Wang J; Huang Q; Chen M
    Chin Med J (Engl); 2003 May; 116(5):747-52. PubMed ID: 12875694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib inhibits TPA-induced MMP-9 and VEGF expression via suppression of ERK/NF-κB pathway in hepatocellular carcinoma cells.
    Chiang IT; Liu YC; Wang WH; Hsu FT; Chen HW; Lin WJ; Chang WY; Hwang JJ
    In Vivo; 2012; 26(4):671-81. PubMed ID: 22773582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L; Zhang Y
    Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of NF-kappaB activation in the apoptosis induced by extracellular adenosine in human hepatocellular carcinoma HepG2 cells.
    Wu LF; Li GP; Su JD; Pu ZJ; Feng JL; Ye YQ; Wei BL
    Biochem Cell Biol; 2010 Aug; 88(4):705-14. PubMed ID: 20651843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of hepatocellular carcinoma cells to Apo2L/TRAIL by a novel Akt/NF-κB signalling inhibitor.
    Omar HA; Arafa el-SA; Maghrabi IA; Weng JR
    Basic Clin Pharmacol Toxicol; 2014 Jun; 114(6):464-71. PubMed ID: 24401154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis.
    Németh J; Stein I; Haag D; Riehl A; Longerich T; Horwitz E; Breuhahn K; Gebhardt C; Schirmacher P; Hahn M; Ben-Neriah Y; Pikarsky E; Angel P; Hess J
    Hepatology; 2009 Oct; 50(4):1251-62. PubMed ID: 19670424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
    Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition and apoptosis induced by osthole, a natural coumarin, in hepatocellular carcinoma.
    Zhang L; Jiang G; Yao F; He Y; Liang G; Zhang Y; Hu B; Wu Y; Li Y; Liu H
    PLoS One; 2012; 7(5):e37865. PubMed ID: 22662241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation.
    Aggarwal S; Ichikawa H; Takada Y; Sandur SK; Shishodia S; Aggarwal BB
    Mol Pharmacol; 2006 Jan; 69(1):195-206. PubMed ID: 16219905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ginsenoside compound K attenuates metastatic growth of hepatocellular carcinoma, which is associated with the translocation of nuclear factor-κB p65 and reduction of matrix metalloproteinase-2/9.
    Ming Y; Chen Z; Chen L; Lin D; Tong Q; Zheng Z; Song G
    Planta Med; 2011 Mar; 77(5):428-33. PubMed ID: 20979019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-146a inhibits cancer metastasis by downregulating VEGF through dual pathways in hepatocellular carcinoma.
    Zhang Z; Zhang Y; Sun XX; Ma X; Chen ZN
    Mol Cancer; 2015 Jan; 14():5. PubMed ID: 25608619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.